VN-100 Ph1/2

A randomized, double-blind, comparative study of VN-100 in healthy adult Japanese volunteers

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080222050

Enrollment

600

Registered

2013-03-27

Start date

2013-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prophylaxis of influenza infection

Interventions

investigational material(s) Generic name etc : VN-100 INN of investigational material : - Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : Intradermal

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy adult Japanese volunteers

Exclusion criteria

Exclusion criteria: 1) Subjects with history of seasonal influenza in the past 6 months 2) Subjects with history of seasonal influenza vaccination in the past 6 months

Design outcomes

Primary

Measure	Time frame
efficacy HI antibody titer	—

Secondary

Measure	Time frame
efficacy Neutralizing antibody titer	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026